Guardant Health Stock News

Hospitals can't do without their products, and demand is rising.

The health diagnostic company''s cancer biomarker test is slowly but surely moving into the mainstream.

Guardant Health <> is set to close higher for the first time in four sessions on Tuesday after the precision oncology company announced a favorable decision on Medicare coverage for…

The health diagnostic company's cancer biomarker test is slowly but surely moving into the mainstream.

It was all about the earnings for the cancer-diagnostics specialist.

It was all about the earnings for the cancer-diagnostics specialist.

Guardant Health, Inc. (GH) Q4 2021 Results - Earnings Call Transcript

Guardant Health press release (GH): Q4 Non-GAAP EPS of -$0.69 beats by $0.39.Revenue of $108.11M (+38.0% Y/Y) beats by $9.39M.Adjusted EBITDA loss was $64.6 million for the…

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, today reported financial results for the quarter and year ended December 31, 2021. Recent Highlights Revenue of $108 million for the fourth quarter of 2021 and $374 million for the full year 2021, an increase of 38% and 30% over the corresponding period of 2020 Repor

Guardant Health (GH) delivered earnings and revenue surprises of 21.24% and 9.78%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors

Gainers: Guardant Health (GH) +37%. Flex FLEX +12%

Guardant Health Inc (GH) shares closed today 10.8% higher than it did at the end of yesterday. The stock is currently down 37.3% year-to-date, down 59.6% over the past 12 months, and up 94.9% over the past five years. Today, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 1.8%. Trading Activity Shares traded as high as $71.27 and as low as $59.57 this week.Shares closed 61.6% below its 52-week high and 16.8% above its 52-week low.Trading volume this week was 9.2% higher than the 10-day average and 32.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 83.3% The company's stock price performance over the past 12 months lags the peer average by 322.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.